Recs

6

MAKO Surgical: Likes and Dislikes

When a company has generated a lot of excitement -- like MAKO Surgical (Nasdaq: MAKO  ) has with its disruptive product and interesting growth story -- and then takes a big hit in share price, it's worth a closer look to see what's going on. In this video, Motley Fool health care bureau chief Brenton Flynn takes a more in-depth look at the company and gives you some reasons you should consider being bullish on MAKO -- and some reasons not to be.

The recent market sell-off of MAKO Surgical shares has many wondering whether the potential growth prospects of the robotic surgery company make this stock a buy or a stock to stay away from. To answer this question, Fool.com analyst and MAKO expert David Meier has authored a premium research report covering all of the must-know details on the company, including key areas to watch and risks looming in the future. As an added bonus, David will keep you informed with a full year of updates and guidance on MAKO Surgical as news breaks. Click here now to learn more and start reading.

Jeff Fischer and team have demystified options. And they can rack up income like $1,030... $2,626... and $3,228 on a schedule you can set your watch by!
That's why we're glad to announce every single one of their closely guarded strategies is available to YOU during May and June – 100% FREE, no strings attached! Just enter your email address in the box below...


Read/Post Comments (1) | Recommend This Article (6)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

  • Report this Comment On November 12, 2012, at 5:40 AM, captainccs wrote:

    The reason why unicompartmental knee replacement has been a small portion of the knee replacement market is because traditional methods have produced poor results. In consequence, doctors have delayed the surgery until a full knee replacement was justified. But once you have a procedure that produces good results, a lot of the cases that would otherwise be delayed, can now be treated earlier with MAKOplasty.

Add your comment.

Compare Brokers

Fool Disclosure

DocumentId: 2105018, ~/Articles/ArticleHandler.aspx, 5/24/2013 9:24:55 PM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Today's Market

updated 8 minutes ago Sponsored by:
DOW 15,303.10 8.60 0.06%
S&P 500 1,649.60 -0.91 -0.06%
NASD 3,459.14 -0.28 -0.01%

Create My Watchlist

Go to My Watchlist

You don't seem to be following any stocks yet!

Better investing starts with a watchlist. Now you can create a personalized watchlist and get immediate access to the personalized information you need to make successful investing decisions.

Data delayed up to 5 minutes

Related Tickers

5/24/2013 4:00 PM
MAKO $11.22 Down -0.07 -0.62%
MAKO Surgical CAPS Rating: *****
ISRG $501.53 Up +23.07 +4.82%
Intuitive Surgical CAPS Rating: ****

Advertisement